Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term tumor. Found 44 abstracts

no pagination
Chroni A, Vu T, Miura S, Kumar S. Delineation of Tumor Migration Paths by Using a Bayesian Biogeographic Approach. Cancers. 2019 Nov 27;11(12).   PMCID: PMC6966534
Ludwig AK, Michalak M, Xiao Q, Gilles U, Medrano FJ, Ma H, FitzGerald FG, Hasley WD, Melendez-Davila A, Liu M, Rahimi K, Kostina NY, Rodriguez-Emmenegger C, Moller M, Lindner I, Kaltner H, Cudic M, Reusch D, Kopitz J, Romero A, Oscarson S, Klein ML, Gabius HJ, Percec V. Design-functionality relationships for adhesion/growth-regulatory galectins. Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2837-42.   PMCID: PMC6386680
Giroux V, Stephan J, Chatterji P, Rhoades B, Wileyto EP, Klein-Szanto AJ, Lengner CJ, Hamilton KE, Rustgi AK. Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem cell reports. 2018 May 16;10(6):1947-58.   PMCID: PMC5993649
Pelosi G, Sonzogni A, Harari S, Albini A, Bresaola E, MarchiĆ² C, Massa F, Righi L, Gatti G, Papanikolaou N, Vijayvergia N, Calabrese F, Papotti M. Classification of pulmonary neuroendocrine tumors: New insights. Translational lung cancer research. 2017 Oct;6(5):513-29.   PMCID: PMC5653522
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RH, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. Cell. 2017 Sep 07;170(6):1109-1119e10.
Shemesh A, Kugel A, Steiner N, Yezersky M, Tirosh D, Edri A, Teltsh O, Rosental B, Sheiner E, Rubin E, Campbell KS, Porgador A. NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint. Oncotarget. 2016 Oct 25;7(43):70912-23.   PMCID: PMC5342598
Feinstein E, Kaliki S, Shields CL, Ehya H, Shields JA. Choroidal metastasis from leiomyosarcoma in two cases. Oman J Ophthalmol. 2014 Jan;7(1):19-21.   PMCID: Pmc4008894
Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere CA. Altered Carcinogenesis and Proteome in Mammary Glands of Rats after Prepubertal Exposures to the Hormonally Active Chemicals Bisphenol A and Genistein. Journal of Nutrition. 2012 Jul;142(7):1382S-1388S.   PMCID: PMC3374674
Hayashi N, Nakamura S, Tokuda Y, Yagata H, Yoshida A, Ota H, Hortobagyi GN, Cristofanilli M, Ueno NT. Serum HER2 levels determined by two methods in patients with metastatic breast cancer. International Journal of Clinical Oncology. 2012 Feb;17(1):55-62.   PMCID: *
Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li TY, Cooper H, Konski A, Farma JM, Sigurdson ER. Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using (18)FDG-PET/CT. Annals of Surgical Oncology. 2012 Jul;19(7):2178-85.
Tchou J, Wang LC, Selven B, Zhang HT, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast Cancer Research and Treatment. 2012 Jun;133(2):799-804.
Turaka A, Buyyounouski MK, Hanlon AL, Horwitz EM, Greenberg RE, Movsas B. Hypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(3):E433-E439.   PMCID: not NIH funded
Zaorsky NG, Buyyounouski MK, Li TY, Horwitz EM. Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation Therapy. International Journal of Radiation Oncology Biology Physics. 2012 Sep;84(1):E13-E17.   PMCID: PMC3423546
Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, McBryan T, Doyle B, McKay C, Oien KA, Enders GH, Zhang RG, Sansom OJ, Adams PD. Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis. Mol Cell. 2011 Apr;42(1):36-49.
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G, Stellani P VP. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 2011 Aug;12(3):169-80.   PMCID: PMC3230481
Palamar M, Thangappan A, Shields CL, Ehya H, Shields JA. Necrotic Choroidal Melanoma With Scleritis and Choroidal Effusion. Cornea. 2009 Apr;28(3):354-6.   PMCID: not NIH funded
Palamar M, Shields CL, Ghassemi F, Ehya H, Shields JA. Choroidal plasmacytoma in a patient with multiple myeloma. Diagnosis by fine-needle aspiration biopsy. Graefes Archive for Clinical and Experimental Ophthalmology. 2008 Aug;246(8):1195-7.
Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. International Journal of Radiation Oncology Biology Physics. 2007 May;68(1):111-8.
Steinberg G, Bahnson R, Brosman S, Middleton R, Wajsman Z, Wehle M. Efficacy and safety of valrubicin for the treatment of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. Journal of Urology. 2000 Mar;163(3):761-7.
Abdollahi A, Getts LA, Sonoda G, Miller PD, Taguchi T, Godwin AK, Testa JR, Hamilton TC. Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells. Journal of the Society for Gynecologic Investigation. 1999 Jan;6(1):32-40.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term tumor

tumor expression carcinoma cancer radiotherapy metastasis eye choroid melanoma therapy angiogenesis interval fine needle aspiration biopsy biomarkers cellular senescence Breast cancer subtypes Mesothelin-Triple negative breast cancer-Chimeric antigen receptor-Immunotherapy ductal pancreatic-cancer antagonists & inhibitors NKp30 administration & dosage dna-sequence amplification brca1 gene CONCURRENT plasmacytoma activation po-2 oncolytic immunotherapy uvea in-vivo cells clinical utility scleritis glycoconjugate necrosis biogeography Brachytherapy mutations pten expression her-2 receptor gene-expression progression migration paths PHASE-II Combined Modality Therapy lectin anti-PD-1 biochemical failure instillation breast-cancer risk Oncolytic Virotherapy adverse effects fdg-pet contribute sites pembrolizumab protection Hypoxia microenvironment Tumor Microenvironment k1 induce apoptosis CHEMOTHERAPY BONE-MARROW in-utero exposure effusion CYTOPROTECTOR AMIFOSTINE radical cystectomy radiation injury Prostate cancer Trastuzumab classification growth arrest subtypes Melanoma Choroid decidua drug pathway lung parasite NKp44 cathepsin B vascular response serum NSCLC radiation-therapy identification progression-free survival monoclonal-antibody positron-emission-tomography chromosome microdissection Eppendorf neoplasms c-erbb-2 protein overexpression epithelial-cells carcinomas signaling rats preoperative chemoradiation therapy Serum HER2 HYPERFRACTIONATED RADIATION keratin 15 lovastatin transitional-cell carcinoma ovarian neuroendocrine tumor invasiveness 1992 ang k-american journal of surgical pathology-v16-p259 nonoperative treatment dispersal genetics courses neu leiomyosarcoma amifostine p53 diagnostics in-situ Biochemical failure oncolytic viruses vessels Breast neoplasm Immunohistochemistry (IHC) survival COMBINED-MODALITY THERAPY RADIATION-THERAPY extracellular domain talimogene laherparepvec annexin-ii menstrual factors proteins oncoprotein non-small-cell lung cancer bevacizumab ovary NECK-CANCER stem cells trastuzumab-based therapy androgen deprivation breast profiling markers locally advanced FRACTIONATED RADIOTHERAPY HER2 basal Herpesviridae
Last updated on Wednesday, August 12, 2020